中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
BNPS-粪臭素 |
BNPS-Skatole |
27933-36-4 |
C15H11BrN2O2S |
|
BMS470539二盐酸盐 |
(2S)-2-Amino-N-[(2R)-1-(4-butanoyl-4-phenylpiperidin-1-yl)-3-(4-methoxyphenyl)-1-oxopropan-2-yl]-3-(3-methylimidazol-4-yl)propanamide |
457893-92-4 |
C32H41N5O4 |
|
BMS-687453抑制剂 |
BMS-687453 |
1000998-59-3 |
C22H21ClN2O6 |
|
BMS 754807; (2S)-1-[4-[(5-环丙基-1H-吡唑-3-基)氨基]吡咯并[2,1-f][1,2,4]三嗪-2-基]-N-(6-氟-3-吡啶基)-2-甲基-2-吡咯烷甲酰胺 |
BMS-754807 |
1001350-96-4 |
C23H24FN9O |
|
BMS 740808; 1-(3-氨基-1,2-苯并[d]异噁唑-5-基)-3-三氟甲基-6-[4-[2-[[(3R)-3-羟基-1-吡咯烷基]甲基]苯基]苯基]-1,4,5,6-四氢-7H-吡唑并[3,4-c]吡啶-7-酮 |
BMS-740808 |
280118-23-2 |
C31H27F3N6O3 |
|
BMS 554417; 4-[2-[4-[[(2S)-2-(3-氯苯基)-2-羟基乙基]氨基]-1,2-二氢-2-氧代-3-吡啶基]-7-甲基-1H-苯并咪唑-5-基]-1-哌嗪丙腈 |
BMS-554417 |
468741-42-6 |
C28H30ClN7O2 |
|
BMS 378806; 1-[(2R)-4-苯甲酰基-2-甲基-1-哌嗪基]-2-(4-甲氧基-1H-吡咯并[2,3-b]吡啶-3-基)-1,2-乙二酮 |
4-benzoyl-1-[(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2-(R)-methylpiperazine |
357263-13-9 |
C22H22N4O4 |
|
BMIK 双(1-甲基-2-咪唑基)甲酮 |
bis(N-methylimidazol-2-yl)keton |
62366-40-9 |
C9H10N4O |
|
BLU-667(拉西替尼) |
Pralsetinib |
2097132-94-8 |
C27H32FN9O2 |
|
BLI489水合物 |
BLI-489 |
623564-40-9 |
C13H10N3O4S*Na |
|
BL-1021盐酸盐 |
BL-1021 hydrochloride |
1002331-76-1 |
C23H28N2O*ClH |
|
BISTHFHNS衍生物3 |
2,5-dioxopyrrolidin-1-yl ((3R,3aR,6aS)-hexahydrofuro[2,3-b]furan-3-yl) carbonate |
799241-86-4 |
C11H13NO7 |
|
BIS-MUP,二(4-甲基伞形酮)磷酸酯 |
Di(4-methylcumarin-7-yl)phosphat |
51379-07-8 |
C20H15O8P |
|
BIOTIN-六聚乙二醇-叠氮 |
N-(20-azido-3,6,9,12,15,18-hexaoxaicosyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide |
1085938-09-5 |
C24H44N6O8S |
|
BIOTIN-三聚乙二醇 |
5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]-N-[2-[2-(2-hydroxyethoxy)ethoxy]ethyl]pentanamide |
289714-02-9 |
C16H29N3O5S |
|
BIIE 246 |
(S)-N<sup>2</sup>-[[1-[2-[4-[(R,S)-5,11-dihydro6(6h)-oxodibenz[b,e]azepin-11-yl]-1-piperazinyl]-2-oxo-ethyl]-cyclopentyl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3H-1,2,4-triazol-4-yl]ethyl]-argininamid |
246146-55-4 |
C49H57N11O6 |
|
BIIB-024; 6-氨基-5-氯-N-[(1R)-1-[5-[[[5-氯-4-(三氟甲基)-2-吡啶基]氨基]羰基]-2-噻唑基]乙基]-4-嘧啶甲酰胺 |
(R)-2-(1-(6-amino-5-chloropyrimidine-4-carboxamido)ethyl)-N-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide |
1096708-71-2 |
C17H12Cl2F3N7O2S |
|
BIIB 021; 6-氯-9-[(4-甲氧基-3,5-二甲基-2-吡啶基)甲基]-9H-嘌呤-2-胺 |
BIIB021 |
848695-25-0 |
C14H15ClN6O |
|
BIBF1120中间体 |
methyl (E)-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate |
1168150-46-6 |
C18H15NO4 |
|
BI-847325,MEK和极光激酶(AK)的ATP竞争性双重抑制剂 |
(Z)-3-(3-(((4-((dimethylamino)methyl)phenyl)amino)(phenyl)methylene)-2-oxoindolin-6-yl)-N-ethylpropiolamide |
1207293-36-4 |
C29H28N4O2 |
|
BI(甲基硒)乙炔 |
bi(methylseleno)acetylene |
62943-62-8 |
C4H6Se2 |
|
BHQ-1酸,BHQ-1ACID |
BHQ-1 carboxylic acid |
1190431-95-8 |
C26H28N6O5 |
|
BG45,一个HDACI型抑制剂,选择性抑制HDAC3 |
BG45 |
926259-99-6 |
C11H10N4O |
|
BEZ235 对甲苯磺酸盐 |
2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile monotosylate salt |
1028385-32-1 |
C7H8O3S*C30H23N5O |
|
BET溴区抑制剂(CPI-0610) |
2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide |
1380087-89-7 |
C20H16ClN3O2 |
|
BETRIXABAN中间体 |
4-(N,N-dimethylcarbamimidoyl)benzoic acid |
244257-76-9 |
C10H12N2O2 |
|
BETA淀粉样蛋白片段1-40 |
Human beta-amyloid peptide (1-40) |
131438-79-4 |
C194H295N53O58S |
|
BETA2-澳洲茄边碱 |
L-Rhamnopyranosyl-14-D-glucopyranose solasodine |
32449-98-2 |
C39H63NO11 |
|
BETA-雌二醇 3-硫酸钠盐 |
(17β)-3-(sulfooxy)estra-1,3,5(10)-trien-17-ol sodium salt |
4999-79-5 |
C18H23O5S*Na |
|
BETA-萘乙酸甲酯 |
methyl 2-naphthylacetate |
2876-71-3 |
C13H12O2 |
|
BETA-胡萝卜素 |
Perhydro-β-carotin |
17161-33-0 |
C40H78 |
|
BETA-育亨宾 |
(+/-)-β-yohimbine |
549-84-8 |
C21H26N2O3 |
|
BETA-白檀酮 |
β-amyrone |
638-97-1 |
C30H48O |
|
BETA-环丙基-4-氟-3-甲基苯丙酸 |
3-Cyclopropyl-3-(4-fluoro-3-methylphenyl)propanoic acid |
1017330-08-3 |
C13H15FO2 |
|
BETA-烟酰胺腺嘌呤双核苷酸 |
3'-NADPH |
50443-29-3 |
C21H30N7NaO17P3 |
|
BETA-扶桑甾醇氧化物 |
stigmast-4-en-3-one |
1058-61-3 |
C29H48O |
|
BETA-岚香酮酸 |
elemonic acid |
28282-25-9 |
C30H46O3 |
|
BETA-吡咯烷苯丙酮盐酸盐 |
1-phenyl-3-piperidino-propan-1-one; hydrochloride |
886-06-6 |
C14H19NO*ClH |
|
BETA-二甲氨基异丁酸甲酯 |
methyl 3-dimethylamino-isobutyrate |
10205-34-2 |
C7H15NO2 |
|
BETA-二氢紫罗兰酮 |
4-(2,6,6-Trimethyl-cyclohex-1-enyl)-butan-2-on |
17283-81-7 |
C13H22O |
|
BETA-丙胺酰胺盐酸盐 |
3-aminopropanamide hydrochloride |
64017-81-8 |
C3H8N2O*ClH |
|
BETA-丙内酯 |
potassium (1E,3E)-5-oxopenta-1,3-dien-1-olate |
40418-44-8 |
C5H5O2*K |
|
BETA-[[叔丁氧羰基]氨基]环戊烷丙酸 |
3-tert-butoxycarbonylamino-3-cyclopentylpropionic acid |
776330-74-6 |
C13H23NO4 |
|
BETA-[[叔丁氧羰基]氨基]-1-[(苯基甲氧基)羰基]-4-哌啶丙酸 |
3-(1-((Benzyloxy)carbonyl)piperidin-4-yl)-3-((tert-butoxycarbonyl)amino)propanoic acid |
886362-33-0 |
C21H30N2O6 |
|
BETA-D-葡萄糖脱氢酶 |
glucose 1-dehydrogenase (NADP+) |
37250-50-3 |
—— |
——
|
BETA-D-吡喃葡萄糖醛酸1-[N-[(1R)-3-[5,6-二氢-3-(三氟甲基)-1,2,4-三唑并[4,3-A]吡嗪-7(8H)-基]-3-氧代-1-[(2,4,5-三氟苯基)甲基]丙基]氨基甲酸酯] |
beta-D-Glucopyranuronic acid, 1-[N-[(1R)-3-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]carbamate] |
940002-59-5 |
C23H23F6N5O9 |
|
BETA-1,3-葡聚糖 |
(2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5S)-3,5-dihydroxy-2-(hydroxymethyl)oxan-4-yl]oxy-4-[(2S,3R,5S,6R)-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-3,5-diol |
9012-72-0 |
C18H32O14 |
|
BENZOICACID,4-鈥媅3-鈥媅(4-鈥媘ETHYLPHENYL)鈥媡HIO]鈥鈥-鈥媅[(4-鈥媘ETHYLPHENYL)鈥媡HIO]鈥媘ETHYL]鈥鈥-鈥媜XOPROPYL]鈥 |
4-(3-(p-tolylthio)-2-((p-tolylthio)methyl)propanoyl)benzoic acid |
124242-93-9 |
C25H24O3S2 |
|
BENZOICACID,4-鈥媅3-鈥媅(4-鈥媘ETHYLPHENYL)鈥媠ULFONYL]鈥鈥-鈥媅[(4-鈥媘ETHYLPHENYL)鈥媠ULFONYL]鈥媘ETHYL]鈥鈥-鈥媜XOPROPYL]鈥 |
4-[2,2-bis[(p-tolylsulfonyl)-methyl]acetyl]benzoic acid |
124243-00-1 |
C25H24O7S2 |
|
BENZIMIDAVIR苯并咪唑核苷 |
maribavir |
176161-24-3 |
C15H19Cl2N3O4 |
|